Cytogenetic analyses have revealed that complex karyotypes with numerous and highly variable genomic aberrations including single-nucleotide polymorphisms (SNPs) and copy number variants (CNVs), are observed in most of the conventional osteosarcomas (OSs). Several genome-wide studies have reported that the dysregulated expression of many genes is correlated with genomic aberrations in OS. We first compared OS gene expression in Gene Expression Omnibus (GEO) data sets and genomic aberrations in International Cancer Genome Consortium (ICGC) database to identify differentially expressed genes (DEGs) associated with SNPs or CNVs in OS. Then the function annotation of SNP-or CNV-associated DEGs was performed in terms of gene ontology analysis, pathway analysis and protein-protein interactions (PPIs). Finally, the expression of genes correlated with both SNPs and CNVs were confirmed by quantitative reverse-transcription PCR. Eight publicly available GEO data sets were obtained, and a set of 979 DEGs were identified (472 upregulated and 507 downregulated DEGs). Moreover, we obtained 1039 SNPs mapped in 938 genes, and 583 CNV sites mapped in 2915 genes. Comparing genomic aberrations and DGEs, we found 41 SNP-associated DEGs and 124 CNV-associated DEGs, in which 7 DGEs were associated with both SNPs and CNVs, including WWP1, EXT1, LDHB, C8orf59, PLEKHA5, CCT3 and VWF. The result of function annotation showed that ossification, bone development and skeletal system development were the significantly enriched terms of biological processes for DEGs. PPI network analysis showed that CCT3, COPS3 and WWP1 were the significant hub proteins. We conclude that these genes, including CCT3, COPS3 and WWP1 are candidate driver genes of importance in OS tumorigenesis.
INTRODUCTION
Osteosarcoma (OS) is one of the most prevalent forms of malignant bone cancer that occurs predominantly in children and adolescents. 1, 2 With current treatment, the 5-year survival rate for people with localized OS is in the range of 60-80%. However, if the OS has already spread when it is first found, the 5-year survival rate is~15-30% (http://www.cancer.org/cancer/osteosarcoma). Because of its high metastatic potential, usually in lung, OS has become the second highest cause of cancer-related death in these age groups. 3 Thus, there is an urgent need for the understanding of underlying mechanism of OS.
There are considerable studies about exploring the mechanism of OS. The dysregulation of multiple intracellular signaling pathways has been reported in the initiation and development of this disease, including phosphatidylinositol 3-kinase/Akt pathway, Wnt pathway and JAK2/STAT3 signaling pathway. [4] [5] [6] The expression of the Notch1 intracellular domain in immature osteoblasts was sufficient to drive the formation of bone tumors, including OS. 7 Based on the studies, Notch activation may act as a driver of OS. Despite the exciting progress on the disease, the etiology of OS is not fully elucidated.
Cytogenetic analyses have revealed that complex karyotypes with numerous and highly variable genomic aberrations including single-nucleotide polymorphisms (SNPs) and copy number variants (CNVs), are observed in most of the conventional OS. 8 Several genome-wide studies have reported that the dysregulated expression of many genes is correlated with genomic aberrations in OS. Indeed, recent studies have shown that alterations in SNPs are of great importance as they can affect gene expression levels, alternative splicing, DNA methylation and miRNA-mediated gene expression levels in different types of cells. 9 Similarly, CNVs have been associated with changes in gene expression values in various cell types. 10, 11 In this paper, we identified the differentially expressed genes (DEGs) between OS and control tissues. Then, the important DEGs containing SNPs and CNVs were analyzed by gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment. The whole-genome analysis will reveal new genetic mutations associated with OS.
MATERIALS AND METHODS

The gene expression and genomic aberrations data in OS
The gene expression profiling of OS was obtained from Gene Expression Omnibus (GEO; available at http://www.ncbi.nlm.nih.gov/geo/) database. 12 The following key words and their combinations were used: homo sapiens and OS. The data sets that were obtained from array were downloaded. Raw data were preprocessed via background correction and normalization, and the significance analysis of microarray was used to identify DGEs between OS and the controls. Genes with false discovery rate o0.05 were considered as DEGs.
Moreover, raw data for SNP and copy number variation of OS can be obtained from International Cancer Genome Consortium (ICGC; https://dcc.icgc.org/) database. After screening the raw data of BOCA-UK (Bone Cancer UK) project in ICGC database, genes with SNPs or CNVs were obtained.
To know whether genomic aberrations affected gene expression in OS, we compared genes with SNPs or CNVs in OS and DEGs between OS and controls to identify SNP-or CNV-associated DEGs. In the present study, the DGEs with both SNPs and CNVs were considered as key DGEs in OS.
GO and pathway enrichment analysis
The Database for Annotation, Visualization and Integrated Discovery (DAVID) 13 is the most common tool to analyze the functional enrichment of genes. To identify the functions of SNP-or CNV-associated DEGs, the DAVID was used to identify the significantly enriched GO categories, 14 and the pathway enrichment analysis was also conducted by using the KEGG database. 15 The P-value o0.05 was selected as the cutoff criterion.
Protein-protein interaction network construction
For the genes whose expression was associated with both SNPs and CNVs, and DEGs with more than one SNP or CNV in the study population, protein-protein interaction (PPI) analysis was performed using Cytoscape software (San Diego, USA). 16 Biological General Repository for Interaction Datasets (BioGRID) was used for the analysis. 17, 18 Collection of clinical specimens The tissue samples were obtained from six patients diagnosed with OS, and patient consent was also obtained. In addition, the project was approved by our institutional ethics committee. The tumor tissues were dissected during operation, and the nearby normal tissues were used as controls. Both tumor and normal tissue samples were immediately frozen in liquid nitrogen.
Quantitative reverse-transcription PCR
The total RNA from each sample was extracted using TRIzol method (Beijing DingGuo ChangSheng Biotechnology Co., Ltd, Beijing, China). Primer 5.0 software (PREMIER Biosoft, Palo Alto, CA, USA) was used to design primers for SYBR Green experiments based on template sequences, and an ABI 7500 real-time PCR system (Applied Biosystems, Carlsbad, CA, USA) was used. For each replicate, cDNA was synthesized from 1 to 5 μg RNA using SuperScript reverse transcriptase II (TOYOBO, Shanghai, China). The quantitative reverse-transcription PCR reaction consisted of 12.5 μl of Power SYBR Green PCR master mix (Applied Biosystems/Life Technologies, Carlsbad, CA, USA), 1 μl diluted cDNA and 0.25 μl of each primer (10 μM) contributing a total volume of 25 μl. Reactions were conducted in triplicate, and run in 96-well plates with the following conditions: 94°C for 2 min, 35 cycles of 94°C for 30 sec, 55°C for 30 sec, 72°C for 30 sec and 72°C for 10 min. Relative gene expression was analyzed using DataAssist Software version 3.0 (Applied Biosystems/Life Technologies), using human actin gene as endogenous controls for RNA load and gene expression in analysis. All experiments were performed in triplicate.
Comparisons between treatment groups and controls were conducted with Student's t-test. Po0.05 was considered to indicate a statistically significant difference. The sequences of PCR primers used for quantitative reverse-transcription PCR were listed in Supplementary Table S1 .
RESULTS
The correlation between genomic aberrations and gene expression
A total of eight expression profiling studies met the inclusion criteria and were included. The characteristics of the individual studies for integrated analysis were displayed in Supplementary  Table S2 . Of these studies, 240 cases of OS and 35 cases of controls were contained. By integrated analysis, a set of 979 DEGs were identified in OS compared with normal tissues, including 472 upregulated and 507 downregulated DEGs ( Supplementary  Table S3 ). After screening the data in BOCA-UK (Bone Cancer UK) project from ICGC repositories, we obtained 1039 SNPs mapped in 938 genes from 65 donors ( Supplementary Table S4 ), and 583 CNVs sites mapped in 2915 genes from 48 donors ( Supplementary  Table S5 ).
Comparing with the genes with SNPs or CNVs in OS, we found 41 SNP-associated DEGs, 124 CNV-associated DEGs, in which seven DGEs occurred in both SNPs and CNVs, including WWP1 (WW domain-containing E3 ubiquitin protein ligase 1), exostosin glycosyltransferase 1 (EXT1), lactate dehydrogenase B (LDHB), C8orf59, PLEKHA5, CCT3 (chaperonin containing TCP1, subunit 3) and VWF (Table 1) .
Functional and signal pathway annotation
The functional enrichment analysis was conducted for the SNP and CNV corresponding genes, respectively. In the analysis, six molecular functions and 15 biological processes were enriched for genes related to SNPs ( Table 2 ). The functional annotation of CNV-related genes was also presented ( Table 3 ). The result showed that ossification, bone development and skeletal system development were the significantly enriched terms of biological processes for DEGs. KEGG pathway enrichment analysis showed that SNP-related genes were highly enriched in extra-cellular matrix-receptor interaction and focal adhesion, and CNV corresponding genes were mostly enriched in gap junction, nitrogen metabolism, complement and coagulation cascades, melanoma and prostate cancer (Tables 4 and 5 ).
PPI network construction
By using Cytoscape software, we established PPI networks containing 303 nodes and 328 edges for the genes whose expression was associated with both SNPs and CNVs, and DEGs with more than one SNP or CNV in the study population. The significant hub proteins contained CCT3 (degree = 78), COPS3 (degree = 54) and WWP1 (degree = 52; Figure 1 ). All the genes except COL2A1, ELN and EXT1 had indirect interactions with others.
The expression of key genes associated with both SNP and CNV To verify the differential expression of key genes associated with both SNPs and CNVs, quantitative reverse-transcription PCR was performed. As displayed in Figure 2 , WWP1, EXT1, LDHB, C8orf59, PLEKHA5 and CCT3 were greatly upregulated in OS compared with that in controls, while the expression of VWF was downregulated in OS. 
DISCUSSION
OS is a very heterogeneous and genomically unstable tumor. Co-occurring genomic alterations and gene expression changes can be determined to identify putative driver genes in OS because passenger-and tissue-specific genes will be largely eliminated. In this study, we performed an integrated analysis of eight publicly available GEO data sets and genomic alteration data of SNPs or CNVs to identify biological mechanisms involved in the pathogenesis of OS.
To better understand OS genesis, many studies suggested potential candidate genes and showed genomic alterations driving OS development, and some interesting findings were observed from bioinformatics. [19] [20] [21] [22] [23] A previous research showed that a total of 1170 DEGs were screened (530 upregulated and 640 downregulated) from GSE28424 microarray, and RPL8, PLCG1, PLCG2, SYK, MAD2L1, AURKA, CDCA8, BUB1 and MELK were supposed to be involved in OS. 22 In our study, a set of 979 DEGs were identified in OS compared with normal tissues, including 472 upregulated and 507 downregulated DEGs. The result of function annotation showed that ossification, bone development and skeletal system development were the significantly enriched terms of biological processes for DEGs, which may be involved in the progression of OS.
It was reported that several genomic alterations were most associated with OS, including LRP1-SNRNP25 and KCNMB4-CCND3 fusion genes, VEGF and Wnt signaling pathway alterations, WWOX deletion and amplification of APEX1 and RUNX2. 23 In addition, it was suggested that EZR, CDKN2A and MAP3K5 were with possible prognostic significance in OS. 21 Even then, no new therapies with a significant impact on survival have been developed in the past decades. 20 In the present study, by comparing the genes with SNPs or CNVs in OS and 979 DEGs between OS and control, 41 SNP-associated DEGs and 124 CNV-associated DEGs were obtained, in which 7 DEGs occurred in both SNPs and CNVs, including WWP1, EXT1, LDHB, C8orf59, PLEKHA5, CCT3 and VWF, indicating that they may be important driver genes in OS.
WWP1 is an E3 ubiquitin ligase and was first identified by its WW domain. 24 Recently, it was reported that knockdown of WWP1 can inhibit growth and induce apoptosis in hepatoma carcinoma cells through the activation of caspase-3 and p53. 25 The results provided a hint that WWP1 may take part in the process of OS.
EXT1 encodes an endoplasmic reticulum-resident type II transmembrane glycosyltransferase involved in the chainelongation step of heparan sulfate biosynthesis. Mutations in this gene cause the type I form of multiple exostoses. Mutations in the EXT1 and EXT2 genes were observed in Spanish patients with multiple osteochondromas. 26 Interestingly, our study also showed that EXT1 occurred in both SNPs and CNVs in OS, which suggested that EXT1 will be an important driver gene for the development of OS.
LDHB encodes an enzyme, which catalyzes the reversible conversion of lactate and pyruvate, and NAD and NADH, in the glycolytic pathway. The gene had been reported in the development of panic disorder. 27 However, its role in the process of OS has been still unknown.
CCT3 is the most significant hub protein with the highest degree of connectivity (degree = 78) in PPI network. As a chaperone, CCT3 played an important role in the folding of cytoskeletal components. 28 In hepatocellular carcinoma, CCT3 was identified as an overexpressed gene. 29, 30 In our present study, CCT3 was also upregulated in OS compared with the control. Moreover, both SNP and CNV occurred in CCT3. Its genomic aberrations and gene expression changes indicated that CCT3 is an OS-specific driver gene, and it can be an excellent candidate biomarker for OS diagnosis.
In addition, COPS3 was one of the three hub proteins (CCT3, COPS3 and WWP1) with high connectivity degree in PPI network. COPS3 (COP9 signalosome subunit 3) is located in 17p11, encoding a component of the proteasome pathway. Interestingly, previous studies also showed that the amplification and overexpression of COPS3 potentially targeted TP53 for proteasome-mediated degradation in OSs. 28 And it was reported that COPS3 is a candidate oncogene of importance in OS tumorigenesis. 31 Functional studies will be needed to test for their oncogenic potential.
The proteins associated with the same disease are more likely to interconnect between each other. In our present study, the PPI network analysis showed that all the genes except COL2A1, ELN and EXT1 had indirect interactions with others. Interestingly, the indirect interconnectivity of 12 genes (including CCT3, COPS3, WWP1, LDHB, VWF, PLEKHA5, OFOXD1, MLLT11, C8orf59, MRPS21, WNT5B and PRPSAP2) were through the same protein HMG20, which suggested that all of them may make a 'cross-talk' to each other and involve in the OS tumorigenesis.
CONCLUSION
To conclude, our systematic screening of gene expression data sets and genomic aberration data have yielded 41 SNP-associated DEGs and 124 CNV-associated DEGs in OS, in which 7 genes were associated with both SNPs and CNVs, including WWP1, EXT1, LDHB, C8orf59, PLEKHA5, CCT3 and VWF. Most of them were the important driver genes in OS. Moreover, the three hub proteins, CCT3, COPS3 and WWP1, may play an important role in the development of OS. Our study revealed that studying tumor biology and pathology in a systematic manner can result in a better understanding of osteosarcomagenesis, and can potentially identify new biomarkers for improvement of diagnosis and as possible targets for therapeutic intervention in OS.
